SINGAPORE, Apr 19, 2023 - (ACN Newswire via SEAPRWire.com) - Aquilius Investment Partners ("Aquilius" or the "Firm"), a Singapore based investment manager focused on secondaries in the Asia Pacific region, has announced the final closing of its maiden AIP Secondary Fund I, LP. ("AIP SF I"), at over US$400 million in client commitments. Alongside these commitments, the Firm has raised an additional US$200m of managed accounts available for co-investments from its investors. AIP SF I's limited partners include global institutional investors such as sovereign wealth funds, endowments, and family offices.Christian Keiber, Founding Partner, said: "We have seen strong institutional demand for our dedicated Asia secondaries strategy and are grateful for the trust that our clients have placed in us with the closing of our maiden fund. As investment managers, we seek to provide our clients with a differentiated, lower-risk access to Asia's private markets and we are excited by the market opportunity, which continues to grow rapidly across both traditional LP secondaries and more complex GP-led secondaries transactions."Through AIP SF I, Aquilius is targeting investments in traditional and n...

Vancouver, BC, Apr 19, 2023 - (ACN Newswire via SEAPRWire.com) - Doubleview Gold Corp. (TSXV: DBG) (OTCQB: DBLVF) (FSE: A1W038) (the "Company or "Doubleview") is pleased to announce that following discussions with the Company's technical advisors regarding metallurgical matters related to its Hat Project, assay results will be reported as Copper Equivalent ("CuEq") which will include gold, cobalt and scandium in addition to copper.Doubleview's Hat Project metallurgical studies have been managed by EUR ING Andrew Carter B.Sc. CEng. MIMMM, MSAIMM SME of Tetra Tech, Geo-Environment & Mining Services. The Hat Project is located in the Atlin Mining District of northwestern British Columbia.Table 3 presents drill core assay and Copper Equivalent values for copper, gold, cobalt, and scandium. Copper Equivalent values also recognize recoverability of metals and metal prices. Assay data included in Table 3 has been previously released. Future drilling, metallurgical work, and modeling may result in different outcomes. Metal prices and markets are highly variable and current estimates may differ from those realized in future.Inclusion of scandium in Hat Project Copper Equivalent values s...

WOOD DALE, IL, Apr 18, 2023 - (ACN Newswire via SEAPRWire.com) - Optimas Solutions, a global industrial manufacturer/distributor and service provider, announced today the appointment of Phil Battaglia as Chief Financial Officer. Battaglia possesses over 25 years of financial management and reporting expertise, most recently leadership experience at Caterpillar Inc.Phil Battaglia, CFO of Optimas Solutions. Phil Battaglia comes from Caterpillar to become Optimas Solutions' new CFO."We are delighted to have Phil on board in such an important role for us," said Daniel Harms and Mike Tuffy, Optimas' dual CEOs. "As we continue to elevate our business, we needed someone in our CFO position with the financial acumen and customer-oriented thinking that Phil brings to us. We believe Phil will be essential to strengthening Optimas' solid financial foundation and partner with us to ultimately enhance how we serve our customers.""Optimas is well positioned for a successful future driven by our customers' needs," Battaglia said. "I think I can bring that customer perspective to Optimas given my experience at Caterpillar. While I was there, I worked with suppliers such as Optimas and understand w...

Hamburg, Germany, Apr 18, 2023 - (ACN Newswire via SEAPRWire.com) - Indonesia is keen to exhibit its openness to investment and collaboration with all countries to achieve common prosperity, and this month, Indonesia has been named the official partner country for the Hannover Messe 2023 in Germany. "Indonesia is open to cooperation and investment, and let us collaborate to achieve common prosperity," President Joko Widodo said during the Hannover Congress Centrum, Germany, on Sunday local time.Indonesia is the official partner country for the Hannover Messe 2023, one of the world's largest trade and industrial fairs. The country is also open to investment and cooperation in developing the downstream process and green economy.With its abundant natural resources, demographic bonus, huge markets, and maintained economy, Indonesia has the capital to be a major player in global industries. "The Making Indonesia 4.0 theme is highly relevant for Indonesia, which is now striving to transform its economy through innovation and technology," President said.Indonesia aims to secure investment worth Rp30 trillion through its participation as the Official Partner Country at Hannover Messe 2023A...

SINGAPORE, Apr 18, 2023 - (ACN Newswire via SEAPRWire.com) - The second annual InsureTech Connect Asia will take place in Singapore from May 30 to June 1, 2023, where insurance industry leaders, professionals, and InsurTech providers from across Asia and beyond will convene to share their successes, strategies, and plans for the future of insurance. The event will kick off with an opening keynote by Sopnendu Mohanty, Chief Fintech Officer at the Monetary Authority of Singapore (MAS). Mr. Mohanty will share his vision of the future of fintech and its impact on the insurance industry. Following the opening keynote, there will be a keynote panel on "Developing a Future Proofed Workforce." The panel will be moderated by Simon Phipps, and will feature Peta Latimer, CEO of Mercer Singapore, Clemens Philippi, CEO Asia of MSIG, and Rishi Srivastava, CEO - Group Agency Distribution of AIA. The panelists will discuss how to develop a workforce that is equipped to tackle the challenges of a rapidly evolving industry.They will be joined by over 200 leaders representing insurance companies, investors and InsurTechs across Asia sharing their insights as they take the stage with interactive panel...

HONG KONG, Apr 18, 2023 - (ACN Newswire via SEAPRWire.com) - Coinweb, a layer-2 protocol unifying blockchain's interoperability, announced the success of integrating four more chains into its expandable blockchain infrastructure. Prior to BNB, Polygon, MultiversX (formerly known as Elrond) and Kujira; Bitcoin, Bitcoin Cash, Litecoin and Ethereum were already part of Coinweb's underlying networks. To date, Coinweb has executed over 4 million transactions since December 2020, and is responsible for an average of 0.3% of all daily transactions being broadcast to the BNB chain in March 2023.With these current eight blockchains integrated, Coinweb continues to prove its bold statement of enabling dApps built on top of Coinweb to take advantage of multiple chains' desired features and the flexibility to migrate seamlessly from one chain to another. Blockchain-agnostic tokens that are created on LinkMint -- Coinweb's cross-chain tokenization platform, will now have the option to choose to be embedded in any of these underlying chains, moving between them without the need to hold gas balances of each native layer-1 token. This removes key bottlenecks in delivering interoperability and brea...

ADELAIDE, AUS & SAN DIEGO, Apr 18, 2023 - (亚太商讯 via SEAPRWire.com) - Avance Clinical是领先的屡获殊荣的澳大利亚和北美生物技术 CRO，为早期生物技术公司提供 GlobalReady 计划以加快获得监管批准的路径，已受邀参加 2023 年欧洲进化峰会（ 2023 年 4 月 20 日至 21 日，瑞士蒙特勒）。小组讨论的重点是临床试验的发展，包括技术、DCT、减少时间和成本、批准的药物开发计划以及后期阶段的全球扩展。Avance Clinical 首席执行官 Yvonne Lungershausen 受邀在 2023 年欧洲进化峰会上分享澳大利亚和美国 CRO 的经验和未来预测，重点是以患者为中心和分散式临床试验 (DCT)。Avance Clinical 最近被 GlobalData 认定为 DCT 技术的全球领导者。Evolution Summit 是一个仅限受邀者参加的高级论坛，汇集了领先的临床研究主管和创新解决方案提供商。峰会的内容与关键的临床研发挑战和兴趣、相关市场发展以及成功先驱采用的实用和进步的想法和策略保持一致。在此处查看完整详细信息 https://www.april23.evolution-summit.com/ Avance Clinical 最近被 GlobalData 和 Clinical Trial Arena 评为 CRO 领域 DCT 技术采用的世界领先者。该报告发现，到 2022 年，46% 的 Avance Clinical 试验纳入了 DCT 技术的一些元素，包括远程医疗、远程监控和数字数据收集。DCT 报告还指出，Avance Clinical 在最新技术方面的员工培训是排名的关键因素。在此处查看完整报告 https://www.clinicaltrialsarena.com/features/year-in-review-dct-2022/ Avance Clinical 独特的临床产品 GlobalReady 使已在澳大利亚完成早期到中期阶段的生物技术公司能够快速无缝地过渡到美国，为 FDA 的批准做准备，所有这一切都由一个 CRO 和两个地区的专门团队完成，从而减少了时间和成本，提供高质量的数据。我们经常指出，目前有超过 280 项全球 III 期试验在澳大利亚进行了 I 期研究，这再次证明了澳大利亚数据在 FDA 和其他主要监管机构中的可接受性。超过 40 家生物技术客户现在正在利用 Avance Clinical 的GlobalReady 计划。这种无缝的 GlobalReady 之旅旨在取得成功，生物技术公司可以：- 利用澳大利亚早期临床试验环境（没有IND 和 43.5% 的退税）- 为后期过渡或扩展到北美 - 无需...

Luxembourg, Apr 18, 2023 - (ACN Newswire via SEAPRWire.com) - Moolec Science SA (NASDAQ:MLEC) ("Company"; "Moolec"), a science-based food ingredient company focused on producing animal proteins in plants through Molecular Farming, announced today it has entered into a Share Purchase Agreement ("Agreement") with Nomura Securities International, Inc. ("Nomura").The Agreement provides for a committed equity financing facility under which the Company has the option, but not the obligation, to sell up to the equivalent of $50 million in aggregate gross purchase price of its ordinary shares to Nomura over a 36-month period, subject to the terms of the Agreement. The Company intends to use the proceeds from any future sales of securities under the financing facility, if it is utilized, for general corporate purposes."We are pleased to partner with Nomura and secure this financing facility," said Jose Lopez Lecube, Moolec Science's Chief Financial Officer. "This new understanding provides Moolec with enhanced financial flexibility to continue driving forward our Molecular Farming Platform and portfolio of products," he concluded.Further details are contained in a Current Report on Form 6-K...

ADELAIDE, AUS & SAN DIEGO, Apr 18, 2023 - (ACN Newswire via SEAPRWire.com) - Avance Clinical the leading award-winning Australian and North American biotech CRO that offers a GlobalReady program to early phase biotech companies to speed up the path to regulatory approval, has been invited to join the Evolution Europe Summit 2023 (Montreux, Switzerland 20 April - 21 April 2023). The panel discussion is focused on the evolution of clinical trials including technology, DCTs, reducing time and cost, drug development planning for approvals, and scaling globally in later phases.Avance Clinical CEO, Yvonne Lungershausen has been invited to share the Australian and US CRO experience and future projections with a focus on patient centricity and Decentralized Clinical Trials (DCTs) at the Evolution Europe Summit 2023.Avance Clinical was recently identified by GlobalData as a global leader in DCT technology.The Evolution Summit is an invitation-only, premium forum bringing leading clinical research executives and innovative solution providers. The summit's content is aligned with key clinical R&D challenges and interests, relevant market developments, and practical and progressive ide...

HONG KONG, Apr 18, 2023 - (ACN Newswire via SEAPRWire.com) - Tianyun International Holdings Limited ("Tianyun International", together with its subsidiaries, (the "Group") (Stock Code: 6836.HK), a leading seller and manufacturer of processed fruit products in the People's Republic of China ("PRC"), is pleased to announce that Mr. Yang Ziyuan, Chairman and CEO of the Group, has been listed in Forbes China's "2023 GBA ESG Entrepreneur 30". This prestigious award recognises companies that have demonstrated excellent efforts and contributions in promoting ESG and was presented to Chairman Yang at the Forbes GBA ESG Economic Forum. The selection of 30 ESG Pioneers in the Greater Bay Area was based on international ESG standards, with corporate leadership, industry foresight, innovation drive, and personal impact as the core dimensions. Mr. Yang Ziyuan, Chairman and CEO of the Group, was presented with the awardMr. Yang Ziyuan was interviewed by Forbes China with the Group's new sports drink productsMr. Yang Ziyuan, Chairman and CEO of the Group, said, "I am deeply honoured to be selected as one of the "2023 GBA ESG Entrepreneurs". As a socially responsible enterprise, Tianyun Internatio...

HONG KONG, Apr 18, 2023 - (亚太商讯 via SEAPRWire.com) - 中国领先的品牌加工水果产品销售商及制造商天韵国际控股有限公司（「天韵国际」及其附属公司统称「集团」，股份代号 : 6836.HK）欣然宣布，集团主席兼行政总裁杨自远先生，荣登福布斯中国「2023大湾区ESG企业家30评选」，颁奖典礼早前于「福布斯2023大湾区ESG经济论坛」上进行，杨主席出席颁奖典礼并获颁发荣誉。该评选为表扬于ESG上有卓越表现之企业，福布斯中国以国际ESG标准评审企业，分别以企业领导力、行业前瞻力、创新驱动力及个人影响力为核心维度，遴选出30位大湾区ESG企业先行者，以作业内之表率，冀望借此肯定企业的努力及贡献，同时宣扬ESG的重要性。集团主席兼行政总裁杨自远先生获颁发荣誉杨自远先生手握集团新运动饮料产品接受福布斯中国的访问集团主席兼行政总裁杨自远先生表示：「今次获选为『2023大湾区ESG企业家』之一，本人深感荣幸。天韵国际作为一家肩负社会责任的企业，我们的绿色产品、人才、企业管治以及绿色低碳发展方向皆遵循可持续发展的ESG理念，并以带动行业践行高质量发展为己任。为配合中国实现『双碳』目标，集团制订环境相关指引及目标，引入加强环境管理项目，以减少碳足迹。我们亦不断提升企业管治水平，提升核心团队凝聚力，履行企业社会责任，以回馈各界持份者的支持及信任。」「产品方面，我们连续获得国家高新技术企业称号，拥有多项发明、实用新型、外观设计专利，通过全面推动产品研发创新和提升食品生产工艺水准，向国内外消费者提供优质、多元化的产品。随着大众健康意识日益增强，功能性运动饮料的市场需求日益上升，我们成功完成研发水果粒维生素运动饮料及水果酵素运动饮料，旨在为消费者提供营养补充和维持身体健康的优质产品。我们坚信，只有在不断提高产品质量和创新能力的同时，才能够真正实现企业的社会责任和ESG发展目标。」「感谢社会各界一直以来对集团的支持及信任，我们将继续坚定履行企业社会责任，提升业务及可持续发展能力，将ESG全面纳入企业营运和业务发展，与员工、客户及社区携手前行，与持份者共同努力以提升其ESG表现，推动可持续高质量发展，为社会、消费者及环境做出更多贡献。」关于天韵国际控股有限公司 (股份代号﹕6836.HK)天韵国际控股有限公司（「本公司」集团「统称（及其附属公司）」主要从事(i) 生产及销售包装于金属罐、塑料杯、玻璃瓶及铝箔袋的加工水果产品、(ii) 生产及销售饮料产品及(iii) 新鲜水果买卖。加工水果产品以自家品牌「缤果时代」、「天同时代」和「果小懒」及原厂委托制造代工销售的方式出售。特色饮料产品以自家品牌「享派Shiok Party」及「妖果季」出售。集团致力于为客户提供健康安全的产品，作为国内外资质认证最为齐全的食品企业之一，时刻紧贴严 格的国际生产...

HONG KONG, Apr 17, 2023 - (ACN Newswire via SEAPRWire.com) - Endurance RP Limited ("Endurance" or the "Company" and collectively with its subsidiaries, the "Group"; stock code: 0575.HK) is pleased to announce its commercial strategic partner Wanbang Biopharmaceutical Co., Ltd. ("Wanbang Biopharmaceutical") has successfully completed the Phase 3 double-blind placebo-controlled study of Senstend(TM) in China for the treatment of premature ejaculation ("PE"). The study recorded excellent positive results which met all four co-primary endpoints of Intra-vaginal Ejaculation Latency Time ("IELT"), Index of Premature Ejaculation ("IPE") Ejaculatory Control and IPE Sexual Satisfaction domains and IPE Distress. Compared to both baseline and placebo, Senstend(TM) produced clinically and statistically significant increases in IELT, ejaculatory control and satisfaction and reduction in distress. Consistent with our previous studies undertaken in Europe and the United States ("US"), Senstend(TM) was well-tolerated by both Chinese patients and partners and no new side effects were reported. In this study, there was a study population of 295 male patients aged 20 years or above who were diagnosed...

HONG KONG, Apr 17, 2023 - (亚太商讯 via SEAPRWire.com) - 寿康集团有限公司（「寿康集团」或「本公司」及其附属公司，统称「本集团」；股份代号：0575.HK）欣然公布，其商业战略合作伙伴江苏万邦生化医药集团有限责任公司（「江苏万邦医药」）在中国进行的Senstend™治疗早泄（「早泄」）的第三期双盲安慰剂对照研究已经完成。该研究取得十分优秀的成果，已达到阴道内射精潜伏时间（「阴道内射精潜伏时间」）、早泄指数（「早泄指数」）射精控制、早泄指数性满足范畴以及早泄指数困扰的所有四个共同主要终点。与基线及安慰剂相比，Senstend™在阴道内射精潜伏时间、射精控制及满意度方面在临床及数据上的表现显著较好，并减少痛苦。与我们之前在欧洲及美国（「美国」）进行的研究一样，Senstend™得到了中国患者及伴侣的良好耐受，且并无报告新的副作用。该研究共纳入295名20岁或以上，被诊断为早泄的男性患者，其中197名患者被分配到Senstend™组，98名患者被分配到安慰剂组；患者在中国11个地点接受了为期三个月的治疗。集团行政总裁 Jamie Gibson 表示：「中国第三期临床研究的成果既非常重要，亦很优秀，我们对此感到高兴。这巩固了过往欧洲及美国第三期临床研究结果。这是中国监管提交过程中的重要里程碑。我们目前期待我们在中国的商业合作伙伴在2023年第三季度末向国家药品监督管理局（「国家药品监督管理局」）提交新药申请（「新药申请」），并预计12个月后获得批准。」 Jamie Gibson 进一步表示：「Senstend™有望在推出的首年帮助到中国约900万名患者，预计将于第十年增长至逾1亿7,000万名患者。我们强大的合作伙伴江苏万邦医药，其受惠于作为复星网络的一部分，具备建立电子商务平台的营销专业知识，并透过中国最大医药及医疗保健分销商国药控股的医院、诊所及药房网络，建设优良的全国物流及分销网络，以确保Senstend™在中国的商业上成功。」 来自江苏万邦医药按商业里程碑付款安排临床试验的所有成本（包括所有其他相关的监管及Senstend™提交申请成本）均由江苏万邦医药承担。倘国家药品监督管理局授予Senstend™进口许可证，则江苏万邦医药将须向本集团支付5百万美元（或约39百万港元）（扣除中国预扣税前）。此外，Senstend™于中国进行首次商业销售后，江苏万邦医药将须向本集团支付2百万美元（或约15.6百万港元）（扣除中国预扣税前）。此外，诚如2018年12月3日所披露，江苏万邦医药应就下列各项向本集团支付之其他重大付款包括:如集团实现若干年度销售净额里程碑后，江苏万邦医药作出可能最多为25百万美元（或约195百万港元）之付款及本集团将收取收款净额之25%，并在销售净额的基础上按分层百分比计算之特许权使用费，介乎百分之十...

SINGAPORE, Apr 17, 2023 - (ACN Newswire via SEAPRWire.com) - EveLab Insight, a leading provider of AI-driven skin analysis services, has been named one of the top 5 AI companies to watch by The Silicon Review, a prominent platform for business and technology professionals. This recognition underscores EveLab Insight's innovative approach to artificial intelligence and its commitment to building a scientific and evidence-based approach to skincare.EveLab Insight - 5 Best AI Companies to Watch. EveLab Insight has been named one of the top 5 AI companies to watch by The Silicon Review.Widely praised for its ability to accurately identify and quantify complex skin problems, EveLab Insight's skin analytics platform utilizes proprietary AI models and the world's largest image library of dermatologist-labeled skin conditions to detect surface and subsurface skin issues for more than 10 million consumers globally. Working with world-renowned companies such as Dior and Shiseido Effectim, EveLab Insight's platform helps brands improve product recommendations and innovate their R&D efficacy testing.EveLab Insight works at the intersection of two key AI sectors: AI-driven analytics and AI-...

TAIPEI, TAIWAN and SAN FRANCISCO, CA, Apr 17, 2023 - (ACN Newswire via SEAPRWire.com) - HanchorBio Inc., a global clinical-stage biotechnology company developing innovative immuno-biomedicines, announced today that the US. Food and Drug Administration (FDA) has cleared its investigational new drug (IND) application to initiate a multi-regional clinical trial of its independently-developed novel drug candidate, HCB101, for the treatment of patients with advanced solid tumors or relapsed and refractory non-Hodgkin lymphoma.Scott Liu, Ph.D., Founder, Chairman, and Chief Executive Officer of HanchorBio, commented, "Although there is demonstrated history of PD-1/PD-L1 immune checkpoint inhibitors showcasing strong efficacy in a variety of cancers and significantly improved the prognosis of certain cancer patients, there is a large percentage of cancer patients who are either refractory to these immunotherapies or develop resistance. HCB101 is our independently-developed leading candidate to block the "do not eat" signal from the SIRPa-CD47 pathway, sufficiently eliminating tumor cells by macrophage while exhibiting excellent safety profile in our preclinical studies. The FDA clearance o...